U.S. Nebulizer Market Size Worth $435.5 Million By 2025 | CAGR 6.2%

The U.S. nebulizer market size is anticipated to reach USD 435.5 million by 2025, according to a new report by Grand View Research, Inc., expanding at a 6.2% CAGR during the forecast period. Rising incidence of chronic respiratory diseases in U.S., increasing demand for home healthcare devices, and growing geriatric population are among the key factors driving market growth.

Rising incidence of chronic respiratory diseases is a crucial driver for market growth. According to statistics published by the Centers for Disease Control and Prevention (CDC), approximately 18.4 million adults in U.S. suffer from asthma. Chronic obstructive pulmonary disease (COPD) was estimated to be the third leading cause of death in the country in 2014, according to the CDC, with around 15.7 million Americans diagnosed with the condition that year. Factors such as overconsumption of tobacco and alcohol, unhealthy diet, lack of physical activity, and alarming rates of obesity are also likely to lead to an increase in incidence of respiratory disorders in U.S., contributing to the growth of the nebulizer market over the forecast period.

Home healthcare devices have been gaining popularity and market share in recent years. Growing geriatric population in U.S., high incidence of target diseases, and rising need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays. Easy availability of compact nebulizers ideal for home use and technological innovations in nebulizers to reduce noise and improve functionality are increasing their adoption in home healthcare. Moreover, third-party payers, such as insurance companies, favor such devices as they aim to reduce costs while providing quality healthcare services. Such factors are also expected to contribute to market growth.

 To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/us-nebulizer-market

Further key findings from the study suggest:

• Pneumatic nebulizer accounted for the largest share, by product, in 2016. Factors such as high prevalence of respiratory disorders in aging population have contributed to the dominant share commanded by these devices

• Mesh nebulizer is anticipated to be the fastest growing segment over the forecast period. Technological advancements in these devices will propel growth

• Major players in the market include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.

Grand View Research has segmented the U.S. nebulizer market on the basis of product and region:

Nebulizer Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pneumatic

  • Standalone

  • Portable

• Ultrasonic

  • Standalone

  • Portable

• Mesh

Nebulizer Product Outlook (Volume, Units Sold, 2014 - 2025)

• Pneumatic

  • Standalone

  • Portable

• Ultrasonic

  • Standalone

  • Portable

• Mesh